Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Valvular AF ,AF”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07262255
What this trial is testing

WATCHMAN FLX Pro European Registry

Who this might be right for
Non-valvular Atrial Fibrillation (AF)Left Atrial Appendage Closure
Boston Scientific Corporation 1,000
Large-scale testing (Phase 3)Study completedNCT02164864
What this trial is testing

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Who this might be right for
Atrial FibrillationPercutaneous Coronary Intervention
Boehringer Ingelheim 2,725
Not applicableStudy completedNCT02488421
What this trial is testing

Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2

Who this might be right for
Non-valvular Atrial Fibrillation
Bristol-Myers Squibb 38,122
Not applicableStudy completedNCT03315650
What this trial is testing

Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI

Who this might be right for
Non-valvular Atrial FibrillationAcute Coronary SyndromePercutaneous Coronary Intervention+1 more
IHF GmbH - Institut für Herzinfarktforschung 1,632
Not applicableStudy completedNCT01196897
What this trial is testing

Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

Who this might be right for
Atrial Fibrillation
Boston Scientific Corporation 69
Not applicableWithdrawnNCT03508258
What this trial is testing

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

Who this might be right for
Non-valvular Atrial Fibrillation
Bristol-Myers Squibb
Not applicableStudy completedNCT02941978
What this trial is testing

Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF)

Who this might be right for
Patient CompliancePatient Adherence
AHEPA University Hospital 1,140
Post-approval studies (Phase 4)UnknownNCT04135677
What this trial is testing

Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO

Who this might be right for
Left Atrial Appendage ThrombosisThrombiStroke
Shanghai Zhongshan Hospital 826
Large-scale testing (Phase 3)Study completedNCT02942576
What this trial is testing

Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 632
Testing effectiveness (Phase 2)Study completedNCT00623779
What this trial is testing

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

Who this might be right for
Persistent or Permanent Non-valvular Atrial Fibrillation
AstraZeneca 128
Not applicableStudy completedNCT03258645
What this trial is testing

This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,489
Not applicableStudy completedNCT03795298
What this trial is testing

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

Who this might be right for
Atrial Fibrillation
Boston Scientific Corporation 1,600
Not applicableNot Yet RecruitingNCT07747948
What this trial is testing

Population Pharmacokinetics of Apixaban in Asian Patients With Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation (nv AF)
Chulalongkorn University 200
Not applicableStudy completedNCT03362788
What this trial is testing

The Greek AntiPlatElet Atrial Fibrillation Registry.

Who this might be right for
Atrial FibrillationCoronary Artery Disease
Attikon Hospital 654
Not applicableStudy completedNCT03247582
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company 234
Not applicableStudy completedNCT02611635
What this trial is testing

Atrial Fibrillation Patient Preference Study

Who this might be right for
Atrial Fibrillation
Bayer 382
Not applicableActive Not RecruitingNCT04676880
What this trial is testing

Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy

Who this might be right for
Atrial FibrillationAnticoagulants and Bleeding Disorders
R&D Cardiologie 609
Not applicableLooking for participantsNCT06949319
What this trial is testing

Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Atrial Fibrillation New Onset+4 more
Nedim Tojaga 150
Post-approval studies (Phase 4)UnknownNCT02331602
What this trial is testing

Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran

Who this might be right for
Atrial Fibrillation
Yokohama City University Medical Center 200
Not applicableStudy completedNCT07152301
What this trial is testing

Inflammation, Epigenetics in CHF Patients With AF

Who this might be right for
Congestive Heart Failure ChronicAtrial Fibrillation (Permanent)
University of Palermo 164
Next Page